 |
市場調查報告書
商品編碼
2050471
局部鎮痛藥市場：依產品類型、活性成分、劑型、應用、患者群、通路和地區分類Topical Pain Relief Market, By Product Type, By Active Ingredient, By Type, By Application, By Patient Demographics, By Distribution Channel, By Geography |
||||||
價格
簡介目錄
預計到 2026 年，局部止痛藥市場規模將達到 117 億美元，到 2033 年將達到 170.4 億美元。預計從 2026 年到 2033 年，該市場將以 5.5% 的複合年成長率成長。
| 分析範圍 | 分析詳情 | ||
|---|---|---|---|
| 基準年 | 2025 | 市場規模（2026 年） | 117億美元 |
| 效能數據 | 2020-2024 | 預測期 | 2026-2033 |
| 預測期（2026-2033 年）複合年成長率 | 5.50% | 預計金額（2033 年） | 1740億美元 |
近年來，受慢性疼痛盛行率上升、人口老化以及人們對局部鎮痛方案益處的認知不斷提高的推動，局部局部鎮痛市場經歷了顯著成長。局部鎮痛產品透過將活性成分直接輸送到患處，從而緩解局部疼痛，最大限度地減少全身暴露，並降低口服鎮痛藥相關的副作用風險。該市場涵蓋多種產品，例如乳膏、凝膠、噴霧劑、貼劑和軟膏，其活性成分包括非類固醇消炎劑(NSAIDs)、薄荷醇、辣椒素和Lidocaine等。隨著越來越多的消費者尋求安全有效的急性和慢性疼痛管理方案，預計對局部鎮痛產品的需求將持續成長。
市場動態
全球局部止痛藥市場受多種因素驅動，包括慢性疼痛（如關節炎、背痛和運動傷害）盛行率的上升，這些患者需要長期疼痛管理方案。全球人口老化也促進了市場成長，因為老年人更容易患慢性疼痛。此外，人們對口服鎮痛藥副作用的認知不斷提高，促使偏好轉向局部鎮痛產品，這些產品可在局部緩解疼痛的同時最大限度地減少全身性影響。然而，口服藥物和物理治療等其他疼痛管理方法的存在，以及某些局部產品對嚴重疼痛療效不足，可能會限制市場成長。此外，嚴格的新局部鎮痛藥產品核准監管準則也可能為市場參與企業帶來挑戰。儘管有這些限制，但由於對天然和有機鎮痛產品的需求不斷成長、新型給藥系統的開發以及包括電子商務平台在內的配銷通路的拓展，市場仍存在巨大的成長機會。
本報告的主要特點
- 本報告揭示了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
- 此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要公司採取的競爭策略的重要見解。
- 本節根據公司概況、產品系列、主要亮點、財務表現和策略等各種參數，對全球局部鎮痛劑市場的主要公司進行介紹。
- 本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、產品線更新、市場擴張和行銷策略做出明智的決策。
- 《全球局部鎮痛劑市場》報告面向該行業的各種相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
- 相關人員可以透過分析全球局部鎮痛劑市場中使用的各種策略矩陣來促進決策。
目錄
第1章：分析目標與假設
- 分析目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
第3章：市場動態、監管與趨勢分析
- 市場動態
- 促進因素
- 抑制因子
- 機會
- 影響分析
- 主要進展
- 監管趨勢
- 產品上市及核准
- PEST分析
- 波特五力分析
- 企業合併情景
- 產業趨勢
第4章 全球局部止痛藥市場：依產品類型分類（2021-2033 年）
- 凝膠
- 奶油
- 軟膏
- 修補
- 噴
- 滾珠式
第5章 全球局部止痛藥市場：依活性成分分類（2021-2033 年）
- 非類固醇消炎劑（NSAIDs）
- 抗促效劑
- 麻醉劑
- 水楊酸鹽
- 辣椒素
- 薄荷醇
第6章 全球局部止痛藥市場：按類型分類（2021-2033 年）
- 處方止痛藥
- 非處方止痛藥
第7章 全球局部止痛藥市場：依應用領域分類（2021-2033 年）
- 關節疼痛
- 肌肉和關節疼痛
- 腰痛
- 運動傷害
- 神經性疼痛
- 術後疼痛
第8章 全球局部止痛藥市場：依病患群體分類（2021-2033 年）
- 成人
- 老年人
- 兒童
第9章 全球局部止痛藥市場：依通路分類（2021-2033 年）
- 網路藥房
- 零售藥房
- 醫院藥房
- 超級市場和大賣場
- 健康養生專賣店
第10章 全球局部止痛藥市場：按地區分類（2021-2033 年）
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
- 歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
- 中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
- 非洲
- 南非
- 北非
- 中非
第11章 競爭格局
- Johnson & Johnson
- Pfizer Inc.
- GlaxoSmithKline
- Bayer AG
- Novartis AG
- Sanofi SA
- Merck & Co., Inc.
- Abbott Laboratories
- Amgen Inc.
- Teva Pharmaceutical Industries Ltd.
- Astellas Pharma Inc.
- Mylan NV
- Reckitt Benckiser Group plc
- Hisamitsu Pharmaceutical Co., Inc.
- Mentholatum Company, Inc.
第12章 分析師建議
- 機會
- 分析師意見
- Coherent Opportunity Map (COM)
第13章 參考文獻與分析方法
- 參考
- 分析方法
- 關於 Coherent Market Insights
簡介目錄
Product Code: CMI8051
Topical Pain Relief Market is estimated to be valued at USD 11.70 Bn in 2026 and is expected to reach USD 17.04 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 11.70 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.50% | 2033 Value Projection: | USD 17.04 Bn |
The global topical pain relief market has witnessed significant growth in recent years, driven by the increasing prevalence of chronic pain conditions, rising geriatric population, and growing awareness about the benefits of topical pain management solutions. Topical pain relief products offer localized pain relief by delivering active ingredients directly to the affected area, minimizing systemic exposure and reducing the risk of adverse effects associated with oral pain medications. The market encompasses a wide range of products, including creams, gels, sprays, patches, and ointments, formulated with various active ingredients such as non-steroidal anti-inflammatory drugs (NSAIDs), menthol, capsaicin, and lidocaine. The demand for topical pain relief products is expected to continue growing as more consumers seek safe and effective options for managing acute and chronic pain conditions.
Market Dynamics
The global topical pain relief market is driven by several factors, including the rising prevalence of chronic pain conditions, such as arthritis, back pain, and sports injuries, which require long-term pain management solutions. The growing geriatric population worldwide is also contributing to the market growth, as older adults are more susceptible to chronic pain conditions. Moreover, the increasing awareness about the side effects associated with oral pain medications has led to a shift in consumer preference towards topical pain relief products, which offer localized pain relief with minimal systemic exposure. However, the market growth may be restrained by the availability of alternative pain management options, such as oral medications and physical therapy, as well as the limited efficacy of some topical products for severe pain conditions. Additionally, stringent regulatory guidelines for the approval of new topical pain relief products may pose challenges for market players. Despite these restraints, the market presents significant opportunities for growth, driven by the increasing demand for natural and organic pain relief products, the development of novel drug delivery systems, and the expansion of distribution channels, including e-commerce platforms.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global topical pain relief market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Johnson & Johnson, Pfizer Inc., GlaxoSmithKline, Bayer AG, Novartis AG, Sanofi S.A., Merck & Co., Inc., Abbott Laboratories, Amgen Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Mylan N.V., Reckitt Benckiser Group plc, Hisamitsu Pharmaceutical Co., Inc., and Mentholatum Company, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global topical pain relief market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global topical pain relief market.
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2021 - 2033)
- Gels
- Creams
- Ointments
- Patches
- Sprays
- Roll-ons
- Active Ingredient Insights (Revenue, USD Bn, 2021 - 2033)
- Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
- Counterirritants
- Anesthetics
- Salicylates
- Capsaicin
- Menthol
- Type Insights (Revenue, USD Bn, 2021 - 2033)
- Prescription Pain Relief
- Over-the-Counter (OTC) Pain Relief
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Arthritis Pain
- Muscle and Joint Pain
- Back Pain
- Sports Injuries
- Neuropathic Pain
- Post-Surgical Pain
- Patient Demographics Insights (Revenue, USD Bn, 2021 - 2033)
- Adults
- Geriatrics
- Pediatrics
- Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
- Online Pharmacies
- Retail Pharmacies
- Hospitals Pharmacy
- Supermarkets/Hypermarkets
- Health and Wellness Stores
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Johnson & Johnson
- Pfizer Inc.
- GlaxoSmithKline
- Bayer AG
- Novartis AG
- Sanofi S.A.
- Merck & Co., Inc.
- Abbott Laboratories
- Amgen Inc.
- Teva Pharmaceutical Industries Ltd.
- Astellas Pharma Inc.
- Mylan N.V.
- Reckitt Benckiser Group plc
- Hisamitsu Pharmaceutical Co., Inc.
- Mentholatum Company, Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Topical Pain Relief Market, By Product Type
- Global Topical Pain Relief Market, By Active Ingredient
- Global Topical Pain Relief Market, By Type
- Global Topical Pain Relief Market, By Application
- Global Topical Pain Relief Market, By Patient Demographics
- Global Topical Pain Relief Market, By Distribution Channel
- Global Topical Pain Relief Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Topical Pain Relief Market, By Product Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Gels
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Creams
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ointments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Patches
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Sprays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Roll-ons
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Topical Pain Relief Market, By Active Ingredient, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Counterirritants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Anesthetics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Salicylates
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Capsaicin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Menthol
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Topical Pain Relief Market, By Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Prescription Pain Relief
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Over-the-Counter (OTC) Pain Relief
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Topical Pain Relief Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Arthritis Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Muscle and Joint Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Back Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Sports Injuries
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Neuropathic Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Post-Surgical Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Topical Pain Relief Market, By Patient Demographics, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Geriatrics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Pediatrics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Topical Pain Relief Market, By Distribution Channel, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Hospitals Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Supermarkets/Hypermarkets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Health and Wellness Stores
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
10. Global Topical Pain Relief Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Active Ingredient, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Active Ingredient, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Active Ingredient, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Active Ingredient, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Active Ingredient, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Active Ingredient, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GlaxoSmithKline
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bayer AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Astellas Pharma Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mylan N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Reckitt Benckiser Group plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hisamitsu Pharmaceutical Co., Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mentholatum Company, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
